Clearside BioMedical Inc (CLSD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Clearside BioMedical Inc (CLSD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7926
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO – Retinal Vein Occlusion and DME – Diabetic Macular Edema and wet age related macular degeneration (wet AMD). Clearside’s proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company also offers services such as business development, license agreements and contract manufacturing services. It markets its products across the US. Clearside is headquartered in Alpharetta, Georgia, the US.

Clearside BioMedical Inc (CLSD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clearside BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clearside BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Clearside BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Clearside Biomedical Acquires Patent Portfolio for Suprachoroidal Space Drug Delivery from iScience Interventional 10
Venture Financing 11
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 11
Clearside Biomedical Raises US$8 Million In Venture Financing 13
Clearside Biomedical Raises Additional Funds In Series A Financing 15
Equity Offering 16
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 16
Clearside BioMedical Inc – Key Competitors 18
Clearside BioMedical Inc – Key Employees 19
Clearside BioMedical Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2018: Clearside Biomedical announces second quarter 2018 financial results and provides corporate update 21
May 09, 2018: Clearside Biomedical Announces First Quarter 2018 Financial Results 24
Mar 14, 2018: Clearside Biomedical Reports Fourth Quarter 2017 Financial Results 25
Nov 08, 2017: Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update 28
Aug 09, 2017: Clearside Biomedical Announces Second Quarter 2017 Financial Results and Provides Corporate Update 30
May 10, 2017: Clearside Biomedical Announces First Quarter 2017 Financial Results and Provides Corporate Update 32
Mar 14, 2017: Clearside Biomedical Announces Fourth Quarter And Full Year 2016 Financial Results 34
Corporate Communications 36
Sep 27, 2018: Clearside Biomedical appoints Jeffrey Edwards to board of directors 36
Sep 12, 2018: Clearside Biomedical appoints Viral Kansara as Vice President, discovery 37
Sep 11, 2018: Clearside Biomedical names Leslie Zacks as General Counsel and Chief Compliance Officer 38
Sep 06, 2018: Clearside Biomedical further strengthens commercial organization with appointment of lester rodríguez as vice president, quality 39
Jul 11, 2018: Clearside Biomedical Names Carol Hoang As Vice President, Medical Affairs 40
Feb 26, 2018: Clearside Biomedical Appoints William Humphries As Board Chairman And Brion Raymond As Chief Commercial Officer 41
Aug 08, 2017: Clearside Biomedical Announces Changes to its Board of Directors 43
Jan 04, 2017: Clearside Biomedical Appoints Richard Beckman, M.D., as Chief Medical Officer 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Clearside BioMedical Inc, Medical Equipment, Key Facts, 2017 2
Clearside BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clearside BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clearside BioMedical Inc, Deals By Market, 2012 to YTD 2018 8
Clearside BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clearside Biomedical Acquires Patent Portfolio for Suprachoroidal Space Drug Delivery from iScience Interventional 10
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 11
Clearside Biomedical Raises US$8 Million In Venture Financing 13
Clearside Biomedical Raises Additional Funds In Series A Financing 15
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 16
Clearside BioMedical Inc, Key Competitors 18
Clearside BioMedical Inc, Key Employees 19

List of Figures
Clearside BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clearside BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clearside BioMedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Clearside BioMedical Inc (CLSD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Endo International plc:企業の戦略・SWOT・財務情報
    Endo International plc - Strategy, SWOT and Corporate Finance Report Summary Endo International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioChain Institute Inc-医療機器分野:企業M&A・提携分析
    Summary BioChain Institute Inc (BioChain) is a medical device company that designs, develops and markets diagnostic products. The company provides processed bio-sample products and analysis services used in translational medicine, companion diagnostics, and clinical product research and development. …
  • Centre for Drug Design and Discovery-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):企業のM&A・事業提携・投資動向
    Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes b …
  • SK Networks Co Ltd (001740):企業の財務・戦略的SWOT分析
    Summary SK Networks Co Ltd (SK Networks) is a marketing and distribution company. The company operates in diversified businesses including ICT marketing, automotive, hotel and resorts, rental appliances, and chemical material. It offers global trading in industrial materials such as steel, chemicals …
  • Fiat Chrysler Automobiles NV:戦略・SWOT・企業財務分析
    Fiat Chrysler Automobiles NV - Strategy, SWOT and Corporate Finance Report Summary Fiat Chrysler Automobiles NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pan Pacific Hotels Group Ltd:企業の戦略・SWOT・財務分析
    Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • New World Development Company Limited:企業の戦略・SWOT・財務分析
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Enzymatica AB (ENZY):企業の財務・戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and de …
  • Protalix BioTherapeutics Inc (PLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients wi …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Australian Mines Limited:企業の戦略・SWOT・財務分析
    Australian Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Traverse Energy Ltd (TVL):石油・ガス:M&Aディール及び事業提携情報
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆